1. Home
  2. KELYB vs PRTC Comparison

KELYB vs PRTC Comparison

Compare KELYB & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KELYB
  • PRTC
  • Stock Information
  • Founded
  • KELYB 1946
  • PRTC 2015
  • Country
  • KELYB United States
  • PRTC United States
  • Employees
  • KELYB N/A
  • PRTC N/A
  • Industry
  • KELYB Professional Services
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KELYB Consumer Discretionary
  • PRTC Health Care
  • Exchange
  • KELYB Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • KELYB 426.3M
  • PRTC 439.8M
  • IPO Year
  • KELYB N/A
  • PRTC N/A
  • Fundamental
  • Price
  • KELYB $12.11
  • PRTC $17.94
  • Analyst Decision
  • KELYB
  • PRTC Buy
  • Analyst Count
  • KELYB 0
  • PRTC 1
  • Target Price
  • KELYB N/A
  • PRTC $45.00
  • AVG Volume (30 Days)
  • KELYB 195.0
  • PRTC 2.4K
  • Earning Date
  • KELYB 08-07-2025
  • PRTC 04-30-2025
  • Dividend Yield
  • KELYB 2.60%
  • PRTC N/A
  • EPS Growth
  • KELYB N/A
  • PRTC N/A
  • EPS
  • KELYB N/A
  • PRTC 0.21
  • Revenue
  • KELYB $4,451,600,000.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • KELYB $8.06
  • PRTC $35.98
  • Revenue Next Year
  • KELYB $4.08
  • PRTC $115.38
  • P/E Ratio
  • KELYB N/A
  • PRTC $7.92
  • Revenue Growth
  • KELYB N/A
  • PRTC 44.98
  • 52 Week Low
  • KELYB $11.04
  • PRTC $13.30
  • 52 Week High
  • KELYB $22.98
  • PRTC $26.79
  • Technical
  • Relative Strength Index (RSI)
  • KELYB 65.04
  • PRTC 48.72
  • Support Level
  • KELYB $11.30
  • PRTC $17.32
  • Resistance Level
  • KELYB $12.60
  • PRTC $18.06
  • Average True Range (ATR)
  • KELYB 0.04
  • PRTC 0.44
  • MACD
  • KELYB 0.09
  • PRTC -0.20
  • Stochastic Oscillator
  • KELYB 57.76
  • PRTC 43.64

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: